Figure 2.
EMPRISE study outcomes of interest. 3P‐MACE: three‐point major cardiovascular event; AKI, acute kidney injury; CV, cardiovascular; DKA, diabetic ketoacidosis; ESRD, end‐stage renal disease; ED, emergency department; No., number
EMPRISE study outcomes of interest. 3P‐MACE: three‐point major cardiovascular event; AKI, acute kidney injury; CV, cardiovascular; DKA, diabetic ketoacidosis; ESRD, end‐stage renal disease; ED, emergency department; No., number